Global Scale As a CDMO with 6000+ employees and 30 development and manufacturing sites across three continents, Phillips Medisize can support global product launches and ongoing manufacturing at scale. Their proven track record with large OEMs such as Medtronic, Abbott, Boston Scientific, and collaborations with partners like Jabil and Flex demonstrates the ability to navigate regulatory demands and deliver complex devices globally.

Device Connectivity TheraVolt Medical Connectors and TactoTek IMSE partnerships position Phillips Medisize to support next-gen device integration, connectivity, and performance. This creates sales opportunities with OEMs building connected medical devices, IoT-enabled therapies, and complex device assemblies needing validated quality systems.

Inhalation Leadership Phillips Medisize emphasizes inhalation and Dry Powder inhaler platforms, participates in Respiratory Drug Delivery events, and showcases inhaled drug delivery device platforms. This signals opportunities with pharma and biotech players pursuing inhaled therapies that require device development, regulatory support, and manufacturing scale.

Compliance Edge Certifications such as ISO 14644 and ISO 14001, combined with established quality systems across a global manufacturing footprint, position Phillips Medisize as a compliant partner for regulated pharma and medtech products, reducing client risk and easing audits and serial production.

Market Validation Active engagement with industry events and recent partnerships highlight growth signals and a market-ready platform for expansion with ViCentra, Hellokaleido, and respiratory and device connectivity initiatives, providing a strong basis for outreach to other large medtech and pharma manufacturers seeking scale and innovation.